PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$36.39
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 11.26x
- P/E 2026E
- 12.57x
- P/E 2027E
- 10.52x
- P/E 2028E
- 7.90x
- P/S forward
- 1.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 103.35x
- PEG TTM
- 0.13x
- Price / book
- 2.16x
- Price / sales
- 1.95x
- Price / cash flow
- 7.74x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 2.16x
- EV / EBITDA
- 14.06x
- EV / EBIT
- 87.48x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026